{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:43:35Z","timestamp":1775904215108,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006182","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Esp\u00edrito Santo","doi-asserted-by":"publisher","award":["53626060\/2011"],"award-info":[{"award-number":["53626060\/2011"]}],"id":[{"id":"10.13039\/501100006182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00284-023-03588-3","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T08:02:21Z","timestamp":1705478541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Vancomycin Subtherapeutic Concentration on Staphylococcus aureus Isolated from Hemodialysis Patients with Low Serum Trough Concentrations"],"prefix":"10.1007","volume":"81","author":[{"given":"Rodrigo Alto\u00e9","family":"Chagas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana de Souza","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica","family":"de C\u00e1ssia Teixeira Birro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-3128","authenticated-orcid":false,"given":"K\u00eania Val\u00e9ria","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"3588_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2215\/CJN.06270710","volume":"6","author":"C-F Lai","year":"2011","unstructured":"Lai C-F, Liao C-H, Pai M-F et al (2011) Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol 6:167\u2013174. https:\/\/doi.org\/10.2215\/CJN.06270710","journal-title":"Clin J Am Soc Nephrol"},{"key":"3588_CR2","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01590309","volume":"4","author":"SJ Vandecasteele","year":"2009","unstructured":"Vandecasteele SJ, Boelaert JR, De Vriese AS (2009) Staphylococcus aureus infections in hemodialysis: what a nephrologist should know. Clin J Am Soc Nephrol 4:1388\u20131400. https:\/\/doi.org\/10.2215\/CJN.01590309","journal-title":"Clin J Am Soc Nephrol"},{"key":"3588_CR3","first-page":"12","volume":"15","author":"T Eleftheriadis","year":"2011","unstructured":"Eleftheriadis T, Liakopoulos V, Leivaditis K et al (2011) Infections in hemodialysis: a concise review - part 1: bacteremia and respiratory infections. Hippokratia 15:12\u201317","journal-title":"Hippokratia"},{"key":"3588_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/S41581-019-0150-7","volume":"15","author":"TZ Wang","year":"2019","unstructured":"Wang TZ, Kodiyanplakkal RPL, Calfee DP (2019) Antimicrobial resistance in nephrology. Nat Rev Nephrol 15:463. https:\/\/doi.org\/10.1038\/S41581-019-0150-7","journal-title":"Nat Rev Nephrol"},{"key":"3588_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC et al (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the american society of health-system pharmacists, the infectious diseases society of america, and the society of infectious diseases pharmacists. Am J Heal Pharm 66:82\u201398. https:\/\/doi.org\/10.2146\/ajhp080434","journal-title":"Am J Heal Pharm"},{"key":"3588_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1413-8670(10)70041-6","volume":"14","author":"LL Marengo","year":"2010","unstructured":"Marengo LL, Del Fiol FDS, Oliveira SDJ et al (2010) Vancomycin: the need to suit serum concentrations in hemodialysis patients. Braz J Infect Dis 14:203\u2013208. https:\/\/doi.org\/10.1016\/S1413-8670(10)70041-6","journal-title":"Braz J Infect Dis"},{"key":"3588_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/FTD.0000000000000581","volume":"41","author":"MP da Vit\u00f3ria","year":"2019","unstructured":"da Vit\u00f3ria MP, de Alvarenga CG, S, Vasconcellos Filho LM, et al (2019) Low serum trough concentrations and high vancomycin minimum inhibitory concentration in methicillin-sensitive staphylococcus aureus from hemodialysis patients in Brazil. Ther Drug Monit 41:38\u201343. https:\/\/doi.org\/10.1097\/FTD.0000000000000581","journal-title":"Ther Drug Monit"},{"key":"3588_CR8","first-page":"27","volume":"14226","author":"PA Moise-broder","year":"2004","unstructured":"Moise-broder PA, Sakoulas G, Eliopoulos GM et al (2004) Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus Is predictive of failure of vancomycin therapy. Clin Infect Dis 14226:27\u201330","journal-title":"Clin Infect Dis"},{"key":"3588_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/jac\/dkl030","volume":"57","author":"G Sakoulas","year":"2006","unstructured":"Sakoulas G, Gold HS, Cohen RA et al (2006) Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother 57:699\u2013704. https:\/\/doi.org\/10.1093\/jac\/dkl030","journal-title":"J Antimicrob Chemother"},{"key":"3588_CR10","first-page":"14","volume":"2003","author":"BP Howden","year":"2004","unstructured":"Howden BP, Ward PB, Charles PGP et al (2004) Treatment outcomes for serious infections caused by methicillin-resistant staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2003:14\u201317","journal-title":"Clin Infect Dis"},{"key":"3588_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1590\/2175-8239-JBN-2021-0198","volume":"44","author":"FB Nerbass","year":"2022","unstructured":"Nerbass FB, Lima H, do N, Thom\u00e9 FS, et al (2022) Brazilian dialysis survey 2020. J Bras Nefrol 44:349. https:\/\/doi.org\/10.1590\/2175-8239-JBN-2021-0198","journal-title":"J Bras Nefrol"},{"key":"3588_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.idc.2008.10.003","volume":"23","author":"FR DeLeo","year":"2009","unstructured":"DeLeo FR, Diep BA, Otto M (2009) Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 23:17\u201334. https:\/\/doi.org\/10.1016\/j.idc.2008.10.003","journal-title":"Infect Dis Clin North Am"},{"key":"3588_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1128\/jb.64.4.489-499.1952","volume":"64","author":"W Szybalski","year":"1952","unstructured":"Szybalski W, Bryson V (1952) Genetic studies on microbial cross resistance to toxic agents. I. cross resistance of Escherichia coli to fifteen antibiotics. J Bacteriol 64:489\u2013499","journal-title":"J Bacteriol"},{"key":"3588_CR14","unstructured":"CLSI (2017) Performance Standards for Antimicrobial Susceptibility Testing- CLSI supplement M100, 27th ed. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"3588_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-1759(00)00279-9","volume":"245","author":"LE DeForge","year":"2000","unstructured":"DeForge LE, Billeci KL, Kramer SM (2000) Effect of IFN-\u03b3 on the killing of S. aureus in human whole blood. J Immunol Methods 245:79\u201389. https:\/\/doi.org\/10.1016\/S0022-1759(00)00279-9","journal-title":"J Immunol Methods"},{"key":"3588_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V et al (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115:891\u2013899. https:\/\/doi.org\/10.1111\/j.1600-0463.2007.apm_630.x","journal-title":"APMIS"},{"key":"3588_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/AAC.50.2.428","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui L, Iwamoto A, Lian J et al (2006) Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50:428\u2013438. https:\/\/doi.org\/10.1128\/AAC.50.2.428","journal-title":"Antimicrob Agents Chemother"},{"key":"3588_CR18","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1128\/JB.185.24.7103-7110.2003","volume":"185","author":"K Sieradzki","year":"2003","unstructured":"Sieradzki K, Tomasz A (2003) Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 185:7103\u20137110. https:\/\/doi.org\/10.1128\/JB.185.24.7103-7110.2003","journal-title":"J Bacteriol"},{"key":"3588_CR19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1086\/430175","volume":"40","author":"KY Rhee","year":"2005","unstructured":"Rhee KY, Gardiner DF, Charles M (2005) Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York hospital: quantitative testing redux. Clin Infect Dis 40:1705\u20131706. https:\/\/doi.org\/10.1086\/430175","journal-title":"Clin Infect Dis"},{"key":"3588_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/jac\/dkm258","volume":"60","author":"G Steinkraus","year":"2007","unstructured":"Steinkraus G, White R, Friedrich L (2007) Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05. J Antimicrob Chemother 60:788\u2013794. https:\/\/doi.org\/10.1093\/jac\/dkm258","journal-title":"J Antimicrob Chemother"},{"key":"3588_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1128\/JCM.00407-09","volume":"47","author":"EO Mason","year":"2009","unstructured":"Mason EO, Lamberth LB, Hammerman WA et al (2009) Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol 47:1628\u20131630. https:\/\/doi.org\/10.1128\/JCM.00407-09","journal-title":"J Clin Microbiol"},{"key":"3588_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3201\/eid\/1706.101037","volume":"17","author":"JM Aguado","year":"2011","unstructured":"Aguado JM, San-Juan R, Lalueza A et al (2011) High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis 17:1099\u20131102. https:\/\/doi.org\/10.3201\/eid\/1706.101037","journal-title":"Emerg Infect Dis"},{"key":"3588_CR23","doi-asserted-by":"publisher","DOI":"10.1017\/ASH.2023.163","author":"AG Mills","year":"2023","unstructured":"Mills AG, Dupper AC, Chacko KI et al (2023) Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations. Antimicrob Steward Healthc Epidemiol ASHE. https:\/\/doi.org\/10.1017\/ASH.2023.163","journal-title":"Antimicrob Steward Healthc Epidemiol ASHE"},{"key":"3588_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS11060710","author":"H Kato","year":"2022","unstructured":"Kato H, Hagihara M, Kato M et al (2022) A retrospective study on the effectiveness and safety of vancomycin versus daptomycin in hemodialysis patients. Antibiotics. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11060710","journal-title":"Antibiotics"},{"key":"3588_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00042-09","volume":"23","author":"BP Howden","year":"2010","unstructured":"Howden BP, Davies JK, Johnson PDR et al (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23:99\u2013139. https:\/\/doi.org\/10.1128\/CMR.00042-09","journal-title":"Clin Microbiol Rev"},{"key":"3588_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1128\/AAC.00719-07","volume":"52","author":"T Jones","year":"2008","unstructured":"Jones T, Yeaman MR, Sakoulas G et al (2008) Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 52:269\u2013278. https:\/\/doi.org\/10.1128\/AAC.00719-07","journal-title":"Antimicrob Agents Chemother"},{"key":"3588_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1086\/510386","volume":"44","author":"ME Stryjewski","year":"2007","unstructured":"Stryjewski ME, Szczech LA, Benjamin DK et al (2007) Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 44:190\u2013196. https:\/\/doi.org\/10.1086\/510386","journal-title":"Clin Infect Dis"},{"key":"3588_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.diagmicrobio.2011.08.002","volume":"71","author":"EC Clemens","year":"2011","unstructured":"Clemens EC, Chan JD, Lynch JB, Dellit TH (2011) Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 71:408\u2013414. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.08.002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3588_CR29","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1086\/375228","volume":"36","author":"TS Naimi","year":"2003","unstructured":"Naimi TS, Anderson D, O\u2019Boyle C et al (2003) Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Clin Infect Dis 36:1609\u20131612. https:\/\/doi.org\/10.1086\/375228","journal-title":"Clin Infect Dis"},{"key":"3588_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2180-8-39","volume":"8","author":"BP Howden","year":"2008","unstructured":"Howden BP, Smith DJ, Mansell A et al (2008) Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol 8:39. https:\/\/doi.org\/10.1186\/1471-2180-8-39","journal-title":"BMC Microbiol"},{"key":"3588_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1099\/jmm.0.029421-0","volume":"61","author":"L Mehes","year":"2012","unstructured":"Mehes L, Tasko S, Szekely a, et al (2012) Phagocytosis and intracellular killing of heterogeneous vancomycin-intermediate Staphylococcus aureus strains. J Med Microbiol 61:198\u2013203. https:\/\/doi.org\/10.1099\/jmm.0.029421-0","journal-title":"J Med Microbiol"},{"key":"3588_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1574-695X.2011.00846.x","volume":"63","author":"C-Y Hsu","year":"2011","unstructured":"Hsu C-Y, Lin M-H, Chen C-C et al (2011) Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus. FEMS Immunol Med Microbiol 63:236\u2013247. https:\/\/doi.org\/10.1111\/j.1574-695X.2011.00846.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3588_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jobm.201000221","volume":"51","author":"ZA Mirani","year":"2011","unstructured":"Mirani ZA, Jamil N (2011) Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus. J Basic Microbiol 51:191\u2013195. https:\/\/doi.org\/10.1002\/jobm.201000221","journal-title":"J Basic Microbiol"},{"key":"3588_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jhin.2015.04.005","volume":"90","author":"MN Zarpellon","year":"2014","unstructured":"Zarpellon MN, Gales AC, Sasaki AL et al (2014) Survival of vancomycin-intermediate Staphylococcus aureus on hospital surfaces. J Hosp Infect 90:347\u2013350. https:\/\/doi.org\/10.1016\/j.jhin.2015.04.005","journal-title":"J Hosp Infect"},{"key":"3588_CR35","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.1128\/AAC.00568-15","volume":"59","author":"W Chang","year":"2015","unstructured":"Chang W, Ding D, Zhang S et al (2015) Methicillin-resistant Staphylococcus aureus grown on vancomycin-supplemented screening agar displays enhanced biofilm formation. Antimicrob Agents Chemother 59:7906\u20137910. https:\/\/doi.org\/10.1128\/AAC.00568-15","journal-title":"Antimicrob Agents Chemother"},{"key":"3588_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/infdis\/jiu007","volume":"209","author":"W Abdelhady","year":"2014","unstructured":"Abdelhady W, Bayer AS, Seidl K et al (2014) Impact of vancomycin on sara-mediated biofilm formation: Role in persistent endovascular infections due to methicillin-resistant Staphylococcus aureus. J Infect Dis 209:1231\u20131240. https:\/\/doi.org\/10.1093\/infdis\/jiu007","journal-title":"J Infect Dis"},{"key":"3588_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/jac\/41.2.155","volume":"41","author":"ME Rupp","year":"1998","unstructured":"Rupp ME, Hamer KE (1998) Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J Antimicrob Chemother 41:155\u2013161","journal-title":"J Antimicrob Chemother"},{"key":"3588_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1590\/S0074-02762011000100008","volume":"106","author":"ALS Antunes","year":"2011","unstructured":"Antunes ALS, Bonfanti JW, Perez LRR et al (2011) High vancomycin resistance among biofilms produced by Staphylococcus species isolated from central venous catheters. Mem Inst Oswaldo Cruz 106:51\u201355. https:\/\/doi.org\/10.1590\/S0074-02762011000100008","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03588-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03588-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T07:06:12Z","timestamp":1706598372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03588-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3588"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03588-3","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"65"}}